CEUS引导乳腺穿刺活检减少低估率的前瞻性随机研究
本单中心前瞻性随机对照试验纳入340例乳腺病变患者,比较常规超声与CEUS引导下空芯针活检的诊断效能。以手术病理为金标准,CEUS组诊断准确率更高、低估率与假阴性率更低。研究提示CEUS引导可提高活检准确性,尤其适用于绝经前、微钙化及回声不均病变。
要点
- CEUS引导CNB诊断准确率93.5%,高于常规超声的82.4%。
- CEUS组低估率40.7%、假阴性率3.1%,均显著低于常规组。
- 绝经前、微钙化、回声不均病变优先考虑CEUS引导活检。
核心结论
- CEUS引导可提高乳腺空芯针活检准确性,降低假阴性率与低估率。
- CEUS引导能提高浸润性癌穿刺与手术病理之间分子亚型的一致性。
- CEUS引导CNB可优先用于绝经前患者及超声见微钙化或回声不均的病变。
研究设计与样本
- 参与者随机分配接受常规超声引导CNB或CEUS引导CNB,以手术病理为参考标准进行比较。
关键影像表现/征象
- 亚组分析显示CEUS引导CNB在绝经前患者、伴微钙化病变及内部回声不均病变中准确性更优(均P<0.05)。
诊断标准与关键数值
- 以手术病理为金标准,CEUS组诊断准确率93.5%高于常规组82.4%(P=0.02)。
- 总体低估率CEUS组40.7%低于常规组73.2%(P=0.007),假阴性率CEUS组3.1%低于常规组13.9%(P=0.002)。
- 多因素分析显示CEUS引导是活检准确性的独立预测因素(OR 3.094,P=0.004)。
- 浸润性癌患者中活检与手术病理分子亚型一致率CEUS组85.7%高于常规组74.8%(P=0.043)。
- ER、PR、HER-2、Ki-67单项一致性在两组间无显著差异。
临床应用与阅片要点
- 对常规超声显示微钙化或内部回声不均的乳腺病变可优先采用CEUS引导下CNB。
- 绝经前患者采用CEUS引导CNB获益更大,可减少诊断低估。
- CEUS引导可提升浸润性癌分子亚型的术前判定一致性,为个体化治疗提供更可靠依据。
局限性
- 单中心研究,样本量340例,结论外推需多中心验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
UNLABELLED: RATIONALE AND OBJECTIVES: To evaluate whether contrast-enhanced ultrasound (CEUS) guidance improves the diagnostic accuracy of core needle biopsy (CNB) for breast lesions and reduces the underestimation rate, while identifying the patient population most likely to benefit from this approach.
MATERIALS AND METHODS: This single-center prospective randomized controlled trial included 340 patients scheduled for ultrasound-guided breast lesion biopsy at our institution between August 1, 2023, and December 31, 2024. Participants were randomly assigned to receive either conventional ultrasound-guided CNB or CEUS-guided CNB. Using surgical pathology as the reference standard, diagnostic accuracy, underestimation rate (defined as the proportion of cases where high-risk lesions on biopsy were upgraded to malignant lesions on surgical pathology), and agreement with postoperative immunohistochemistry were compared between the two groups. The median age was 53.0 years (interquartile range [IQR], 45.0-66.3 years) in the conventional group and 56.0 years (IQR, 44.8-66.0 years) in the CEUS group, with no significant differences in baseline demographic and clinical characteristics between groups.
RESULTS: The CEUS-guided CNB group demonstrated significantly higher diagnostic accuracy than the conventional group (93.5% vs. 82.4%, P=0.02), along with lower overall underestimation rate (40.7% vs. 73.2%, P=0.007) and false-negative rate (3.1% vs. 13.9%, P=0.002). Multivariate analysis identified CEUS guidance as an independent predictor of biopsy accuracy (OR 3.094, P=0.004). Subgroup analysis showed superior accuracy of CEUS-guided CNB in premenopausal patients, lesions with microcalcifications, and those with heterogeneous internal echoes (all P<0.05). Among patients with invasive cancer, the concordance rate of molecular subtypes between biopsy and surgical pathology was significantly higher in the CEUS group than in the conventional group (85.7% vs. 74.8%, P=0.043), while concordance for ER, PR, HER-2, and Ki-67 did not differ significantly between groups.
CONCLUSION: CEUS can improve the accuracy of core needle biopsy for breast lesions, reducing false-negative rates and underestimation rates. It can enhance the consistency of molecular subtypes between puncture biopsy and surgical pathology in breast cancer patients, providing a stronger basis for clinical decision-making in personalized treatment plans. CEUS-guided CNB may be preferentially considered for premenopausal patients and for lesions with microcalcifications or heterogeneous internal echoes visible on conventional ultrasound.
引用
- Liu, Wang, Tu, et al. CEUS-Guided Core Needle Biopsy Reduces Underestimation in Breast Lesions: A Prospective Randomized Study. Acad Radiol. 2026. PMID: 42632761. doi:10.1016/j.acra.2026.08.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。